EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Essential fatty acids disrupt the mycolic acid-rich cell envelope of clinical Nocardia isolates: a membrane-targeting approach to combat persistent infections

Ming Wei, Shiwang Xie, Peng Wang, Tianmeng Li, Jun Liu, Jingxian Yang, Xinmin Xu, Dan Luo, Li Gu, Shuai Wang

Frontiers in Cellular and Infection Microbiology · 07.08.2026 · 16

DOI: 10.3389/fcimb.2026.1878912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 07.08.2026. Verfasst von Ming Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medica…. Hauptthemen laut MEDLINE: Nocardia, Anti-Bacterial Agents, Nocardia Infections, Cell Membrane. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Conventional antibiotics against slow-growing, mycolic acid-rich Nocardia often require prolonged therapy and are associated with high relapse rates. Membrane-targeting essential fatty acids may circumvent growth-dependent resistance.

Methods

Five essential fatty acids were screened against 82 clinical Nocardia isolates by broth microdilution. Docosahexaenoic acid (DHA) was further assessed for bactericidal kinetics, membrane integrity by propidium iodide staining and scanning electron microscopy, transcriptomic profiling, and combined activity with amikacin and tobramycin. Results α-Linolenic acid, γ-linolenic acid, eicosapentaenoic acid and DHA exhibited comparable activity (MIC 50/ MIC 90 : 31.25/62.50 μM), corresponding to mass concentration ranges of 8.7 to 10.3 μg/mL for MIC 50 and 17.4 to 20.6 μg/mL for MIC 90 . However, arachidonic acid was markedly less active. DHA rapidly disrupted the Nocardia cell envelope, causing propidium iodide influx and ultrastructural damage, and achieved concentration-dependent bactericidal killing within 1 h, a feat not observed with imipenem. Transcriptomic analysis of the surviving subpopulation revealed downregulation of the proton-pumping Nuo complex, upregulation of type II NADH dehydrogenase (Ndh), and global induction of translation machinery. These transcriptional changes, together with pre-existing membrane damage, additively enhanced the activity of amikacin against intrinsically resistant N. wallacei (FICI, 0.51-0.56).

Conclusions

These findings demonstrate that DHA displays rapid membrane-disruptive activity and can enhance amikacin activity against Nocardia under the defined in vitro conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NocardiaAnti-Bacterial AgentsNocardia InfectionsCell MembraneMycolic AcidsCell WallMicrobial Sensitivity TestsHumansAmikacinGene Expression ProfilingTobramycinMicrobial ViabilityMicroscopy, Electron, Scanning

Stichwörter der Autor:innen

Nocardiaamikacin combinationessential fatty acidsmembrane disruptionmycolic acid

Substanzen

Anti-Bacterial AgentsAmikacinMycolic AcidsTobramycin

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • CAS Center for Excellence in Nanoscience, Beijing Key Laboratory of Micro-Nano Energy and Sensor, Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing, China.
  • Department of Clinical Laboratory, Aerospace Center Hospital, Beijing, China.
  • Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • National Institutes for Food and Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, NMPA Key Laboratory for Quality Research…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Wei, M., Xie, S., Wang, P., Li, T., Liu, J., Yang, J., Xu, X., Luo, D., Gu, L., & Wang, S. (2026). Essential fatty acids disrupt the mycolic acid-rich cell envelope of clinical Nocardia isolates: a membrane-targeting approach to combat persistent infections. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1878912

Vancouver

Wei M, Xie S, Wang P, Li T, Liu J, Yang J, et al. Essential fatty acids disrupt the mycolic acid-rich cell envelope of clinical Nocardia isolates: a membrane-targeting approach to combat persistent infections. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1878912

BibTeX
@article{Wei2026,
  author = {Wei, Ming and Xie, Shiwang and Wang, Peng and Li, Tianmeng and Liu, Jun and Yang, Jingxian and Xu, Xinmin and Luo, Dan and Gu, Li and Wang, Shuai},
  title = {Essential fatty acids disrupt the mycolic acid-rich cell envelope of clinical Nocardia isolates: a membrane-targeting approach to combat persistent infections},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1878912}
}
Kostenlos starten →